Medicine in Drug Discovery
SJR1.145
NL
NLJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 1.145 | Q1 | 87.1% | |
| 2024 | — | — | 1.034 | Q1 | 85.1% | |
| 2023 | — | — | 0.815 | Q2 | 80.3% | |
| 2022 | — | — | 1.244 | Q1 | 90.5% | |
| 2021 | — | — | 0.306 | Q3 | 52.0% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2590-0986
country
NLcoverage
2019-2026